Introduction
Streptococcus pneumoniae infections are associated with severe morbidity and substantial mortality [1] [2] [3] [4] [5] . In numerous studies, different predictors influencing the outcome of pneumococcal bacteremia have been identified, including coronary heart disease, neutropenia, and increasing age [1, 3, 5] . On the other hand, the morbidity of severe bacterial infections has been shown to be reduced with the prompt administration of appropriate antibiotic treatment [6] [7] [8] [9] [10] . Benchmarks for the timing of antibiotic therapy have been proposed for different organ system infections: treatment initiation within 4 h is considered to be appropriate for community-acquired pneumonia in people aged more than 65 years, and within 3 h for acute bacterial meningitis [11, 12] . Nevertheless, data on the association between the timeliness of initial diagnostic procedures or the initiation of therapy and outcome are scarce [13] , and it is unknown whether specific benchmarks are applicable in the care of patients with pneumococcal bacteremia.
Within the antibiotic stewardship program at our hospital [14] , we aimed to assess the quality of the initial management of patients with pneumococcal bacteremia, and to compare performance and outcomes with local and international guidelines and benchmarks [11, 12] . Therefore, we studied the associations between the variables ''time to initiation of diagnostic procedures'' (such as imaging, lumbar puncture, or blood culture collection), ''time to initiation of antibiotic therapy'', and in-hospital mortality and length of hospital stay (LOS).
Patients and methods

Ethics statement
Approval by the Research Ethics Board of the Canton of Zurich, Switzerland (address: Kantonale Ethikkommission Zürich, Sonneggstrasse 12, CH-8091 Zürich, Switzerland), was obtained. The ethics committee decided that patients' informed consent was not required because this study was a retrospective quality control project by infectious diseases physicians directly involved in patient care.
Patients and setting
We performed a retrospective study at the University Hospital Zurich, an 800-bed tertiary care teaching hospital that covers all specialties, except pediatrics and orthopedics. Six intensive care units offer a full range of clinical services in different departments of surgery and internal medicine.
The electronic database of the Institute of Medical Microbiology, University of Zurich, where all microbiological samples of the University Hospital Zurich are processed, was used to identify patients with the detection of S. pneumoniae in blood cultures. All patients with a community-acquired episode of pneumococcal bacteremia between January 1, 2003, and March 31, 2009, were eligible for inclusion in the study. An episode of pneumococcal bacteremia was determined by one or more blood culture pairs positive for S. pneumoniae. Isolates from an individual patient were considered to be a single episode if the interval between collections of the isolates was less than 30 days.
Bacteremia was not considered to be communityacquired if the patient was discharged from a hospital less than 7 days before the current hospital admission, if the first blood culture was obtained more than 1 week after hospital admission, or if the patient had no clinical signs and symptoms compatible with pneumococcal infection at the time of admission. We excluded patients who were referred from other hospitals, or who were transferred to another hospital or discharged before the end of treatment.
Data collection
Medical records were reviewed for the following information using a standardized data collection questionnaire: demographics (sex, age, residence prior to hospitalization [home vs. nursing home]), comorbidities (according to the Charlson comorbidity index [CCI]) [15] and the Chronic Disease Score (CDS) [16] , neutropenia (defined as neutrophils \0.5 9 10 9 /L), cardiovascular diseases (such as coronary heart disease, history of myocardial infarction, congestive heart failure, or valvular heart disease), risk behavior (current alcoholism, smoking, injection drug use; as assessed by the admitting physician), prior antibiotic treatment, clinical presentation, initial management (imaging, lumbar puncture [if clinically indicated], blood cultures, and the initialization of antimicrobial therapy; all including the time period from the time of emergency room [ER] admission), laboratory parameters (hemoglobin, hematocrit, thrombocyte count, leucocyte count, blood urea nitrogen, serum creatinine, C-reactive protein, blood glucose, results from blood gas analysis), microbiology (susceptibility testing, serotyping), clinical course (systemic inflammatory response syndrome [SIRS; defined as two or more of the following: temperature (\36°C or [38°C); heart rate [90 beats per min; respiratory rate [20 breaths per min or paCO 2 \ 4.3 kPa; leucocyte count\4,000/lL or [12,000/lL], sepsis (defined as one or more blood culture pairs positive), severe sepsis (defined as one or more blood culture pairs positive AND single organ failure), septic shock (defined as one or more blood culture pairs positive AND multiple organ failure OR need for catecholamines)), complications, and outcome (LOS, death). All times were calculated in relation to the moment of ER admission.
Microbiological analyses
Antimicrobial susceptibility testing for penicillin and ceftriaxone was performed according to the Clinical and Laboratory Standards Institute (CLSI) recommendations at the Institute of Medical Microbiology, University of Zurich [17] . S. pneumoniae was identified using standard methodology, including colonial morphology on blood agar, bile solubility, and susceptibility to optochin. Additionally, all S. pneumoniae strains were then sent to the Swiss National Reference Center for Invasive Pneumococci (NRCP), where serotyping was carried out and susceptibility testing against levofloxacin, erythromycin, and cotrimoxazole was performed. Intermediate resistance was categorized as ''not susceptible''.
Data management and statistical analyses
Data were entered into the EpiData Data Entry, Data Management and Basic Statistical Analysis System 3.1 (EpiData Association, Odense, Denmark, 2008), and then cleaned and manually inspected for errors and outlying values, which were then confirmed or corrected with original records.
Differences in medians, for non-normally distributed data, were analyzed using the Wilcoxon rank-sum test, and differences in means, for normally distributed data, were assessed using Student's t-test. Differences in group proportions were assessed and univariable analyses for risk factors for death were performed using the Chi-square or Fisher's exact test, as appropriate. Multivariable analysis assessing the risk of death was not possible due to the small number of outcomes [18] . We used analysis of variance (ANOVA) to build multivariable models including predictors associated with LOS, treating LOS as a continuous variable.
All statistical analyses were performed using Stata 10.1 (StatCorp, College Station, TX, USA). A two-tailed test of significance with a P-value \0.05 was considered to be statistically significant.
Results
Patient characteristics
A total of 141 blood cultures were tested positive for S. pneumoniae during the study period. Thirty-nine (27.7%) episodes did not meet the inclusion criteria [hospitalacquired infection: 10 (7.1%), transfer to another hospital before the end of treatment: 25 (17.7%), referral from another hospital: 8 (5.7%)]. Four (3.9%) patients had more than one episode of pneumococcal bacteremia, resulting in a total number of 102 episodes from 98 patients being available for analysis. Table 1 summarizes the patient characteristics. The ratio of men to women was 1.4. The most common comorbidities were: chronic liver disease (23.5%), cardiovascular disease (20.6%), chronic renal disease (16.7%), human immunodeficiency virus (HIV) infection (13.7%), chronic respiratory disease (12.7%), and diabetes mellitus The most common diagnosis at discharge was pneumonia (73.5%), followed by meningitis (9.8%). The final diagnoses of otitis media (3.9%), sinusitis (2.9%), and sepsis without focus (1.0%) were less common. More than one diagnosis was made in 7.8% of cases; combinations were pneumonia and otitis media (3.9%), pneumonia and meningitis (2.0%), and pneumonia and arthritis (2.0%).
Outcome
The median [interquartile range (IQR)] LOS was 10 (4-17) days. In 31 (30.4%) cases, the patient had to be admitted to the intensive care unit (ICU), where the median LOS (IQR) was 4 (1-12) days. Sixteen (15.7%) of 98 patients died.
Antimicrobial susceptibility of pneumococcal isolates Data regarding antimicrobial susceptibility could be obtained for 84 (82.4%) isolates. Of five strains (6.0%) with decreased susceptibility to penicillin, four were shown to have a minimum inhibitory concentration (MIC) of between 0.12 mg/L and 1 mg/L, and one had an MIC above 2 mg/L. All strains were susceptible to ceftriaxone. Fifteen (17.9%) strains were not susceptible to cotrimoxazole, eight (9.5%) strains were not susceptible to erythromycin, and one (1.2%) strain was not susceptible to levofloxacin.
Initial diagnostic procedures and time to antimicrobial administration
The times to initial diagnostic procedures are depicted in Table 2 . The median time (IQR) to the first antibiotic dose was 4.0 (2.0-5.9) h (Fig. 1) . In 100 (98.0%) of 102 episodes, the initial antibiotic treatment regimen corresponded to the local guidelines of the University Hospital Zurich. Empirically administered antibiotics did not have antimicrobial activity against S. pneumoniae in two (2.0%) episodes.
Risk factors for death
The following factors were associated with fatal outcome in the univariable analysis: Charlson comorbidity index [odds ratio (OR) (95% confidence interval) per unit increase, 1.3 (1.1-1. CT computed tomography, MRI magnetic resonance imaging (Table 3) . There was no association between fatal outcome and antimicrobial susceptibility rates (data not shown). Overall, no association was found between the rapid initiation of diagnostic steps and survival: the median time (IQR) to blood culture (survivors: Deceased patients received their first dose of antibiotics after a median time (IQR) of 3.3 (1.8-4.3) h, compared to 4.2 (2.0-5.9) h in survivors (P = 0.56) (Fig. 2) . The initial diagnosis did not affect the time to the first antibiotic dose and there was no association between survival and the rapid administration of initial antibiotic therapy; the case fatality rate was 21.9% (7 of 32 episodes) if antibiotics were administered within 4 h of ER admission and 12.5% (4 of 32 episodes) in patients who received their first antibiotic dose more than 4 h after hospital admission (P = 0.32).
Length of hospital stay
The following variables among those assessed as risk factors for death (Table 3) There was no association between the LOS and time to blood culture, time to first antibiotic dose, time to imaging (chest radiograph or brain CT/MRI), and time to lumbar puncture. Multivariable analysis revealed age [60 years (P = 0.048) and alcoholism (P = 0.009) as independent predictors for an increase in the LOS.
Discussion
In this retrospective study of pneumococcal bacteremia in a Swiss university hospital over a 6-year period, we were unable to demonstrate an association between initial patient management and fatal outcome and LOS, respectively. Initial diagnostic steps and antimicrobial therapy were not delayed in deceased patients, and 98% of patients received an initial antimicrobial therapy that was adequate for pneumococcal bacteremia according to local and international guidelines. Factors associated with fatal outcome in the univariable analysis were increasing comorbidity scores, neutropenia, HIV infection, chronic respiratory disease, chronic liver disease, smoking, injection drug use, and previous antibiotic therapy in the past 6 months. Factors independently associated with prolonged LOS were age [60 years and alcoholism.
We were unable to find other studies that assessed the association between early diagnostic and therapeutic management and survival in pneumococcal bacteremia. Several studies have demonstrated that the earlier administration of antibiotics reduces mortality in communityacquired pneumonia [6] [7] [8] 13 ]. There are, however, other data indicating that the early administration of antibiotics does not necessarily lead to better survival [19] . Similar to our results, Cheng and Buising [19] observed that deceased patients with community-acquired pneumonia received their first dose of antibiotics after a median of 1.5 h, in contrast to survivors who received their first dose of antibiotics after a median of 2.9 h. The authors hypothesized that this finding may be due to either a true lack of association, in that minor differences in antibiotic administration within the first 8 h do not affect mortality, or to confounding by severity because patients at the highest risk of death were found to have received antibiotics earlier.
Overall, limitations of the available data result in a continuing debate over the mandate to deliver antibiotics within 4 h of arrival for patients being admitted to the hospital with community-acquired pneumonia [20] . With regards to our study, pneumococcal bacteremia is most often secondary to infections of various organ systems that differ in severity. Thereby, an advantage of survival would be expected predominantly in those individuals who were more severely ill, such as patients with CNS infection [21] , whereas the outcome of infections that develop over a longer period of time may not be affected by differences in the initiation of antimicrobial therapy, if this occurs within a few hours [8] .
Even though the median time to the first dose of antibiotics for pneumonia and meningitis observed in our study met the proposed time limits from earlier publications [11, 12] , it has to be noted that a significant number of patients received delayed initial antibiotic treatment in our dataset. This may result from the wide range of possible presentations of these patients, rendering initial diagnostic and therapeutic choices difficult. Clinical deterioration may be delayed especially in otherwise healthy subjects, possibly explaining the fact that patients at a higher risk for death tend to receive diagnostic and therapeutic steps in a more timely manner. Nevertheless, the overall case fatality rate of 15.7% in our study is below average as compared to other published data, which may be indicative of adequate treatment quality given the case mix that is usually seen in an academic center [1] [2] [3] [4] [5] .
Our study has several limitations. First, the generalizability of our findings may be limited in that we present results from a retrospective study of pneumococcal bacteremia conducted in a single university hospital in Switzerland. The results may be different in other geographic areas and in non-academic centers. Second, our study is limited by the lack of power, in that only 16 deceased patients were detected in a 6-year study period. We were, thus, unable to perform multivariable analysis assessing confounders of the possible association between timely initial management and fatal outcome. Selection bias might have crept in by excluding patients who were transferred to another hospital or discharged before the end of treatment. Patients treated over the entire course of disease at an academic center likely have different characteristics from those discharged on oral antibiotics or transferred to secondary or tertiary hospitals for the completion of treatment. The variability of the duration of infection prior to presentation in the hospital is an additional confounding factor, which inherently renders the interpretation of the findings regarding the interval between hospital presentation and diagnostic and therapeutic measures difficult. Last, the range of conditions varied between the infection of cryptic origin to meningitis, and the impact of delayed antibiotic administration in some of these conditions may be less significant than others. On the other hand, the existing literature suggests that pneumococcal bacteremia, per se, is a strong indicator of a serious clinical condition, irrespective of the origin, and, thus, the variations in clinical conditions may be of less importance [22] .
The findings of this study confirm that pneumococcal bacteremia is a disease with significant morbidity and mortality requiring a timely and adequate initial management. Our results indicate that there is a need for further investigation to help identify patients presenting with atypical clinical symptoms who may be at risk for delayed initial diagnostic and therapeutic management. Larger scale studies are needed in order to draw appropriate conclusions about a mandate to deliver antibiotics within a certain window of time after hospital admission in pneumococcal bacteremia, and, particularly, to characterize populations for which the adherence to such benchmarks improves patient outcomes.
It has to be kept in mind that benchmarks do not necessarily result in improved overall patient care because care providers might focus too much on easily measurable outcome data while neglecting other important challenges. In the field of infectious diseases, an excessively broad and thoughtless application of guidelines may have particularly negative consequences and, at worst, may lead to an increase in adverse events or bacterial resistance rates through an untimely and unnecessary use of antibiotics in viral or other non-bacterial inflammatory diseases [23] . A study on the 4-h antibiotic administration rule, without showing any reduction of mortality, revealed that strict use of this benchmark resulted in the misdiagnosis of pneumonia in almost 20% of patients and, consecutively, to the inappropriate use of antimicrobials [24, 25] .
